Home » Newsletters » BioWorld Science

BioWorld Science

June 18, 2002

View Archived Issues

Novel anticholinergics and their use in asthma, COPD, etc.

Boehringer Ingelheim claims new agents for urinary incontinence

DPP-IV inhibitors and their use in diabetes and related disorders reported by Tanabe

Shionogi develops novel MMP inhibitors

Yamanouchi presents mGluR1 modulators useful in stroke

cGMP-selective PDE inhibitors in early development at Nippon Soda

Preclinical profile of AZD-3582 highlighted at EULAR 2002

Japanese approval obtained for Elaspol

Virucidal activity of liposomal povidone-iodine

Antioxidant and cardioprotective effects of resveratrol and astringinin

MEDICA 16 inhibits hepatic acetyl-CoA carboxylase in insulin-resistant rats

Significant beneficial effects on health-related QOL seen in RA patients treated with CDP-870

Pegylated Axokine enters phase I for treatment of obesity

Patent coverage obtained for Mindset's lead AD therapeutic candidate

Improvement in glucose tolerance in ZDF rats treated with NVP-DPP-728

FDA approves Celebrex labeling changes

Pfizer to return rights to UK-279276 to Corvas

Miltefosine designated an orphan drug for black fever

Essential Therapeutics updates development program objectives

Antidiabetic activity of PPARgamma ligand related to effects on DPP-IV

Chromium supplementation lowers blood glucose, insulin requirements in type 2 diabetes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...